Global Muscarinic Acetylcholine Receptor M2 Trends, Regulations and Competitive Landscape Outlook To 2021

Healthcare

Healthcare

PUNE, MAHARASHTRA, INDIA, April 12, 2018 /EINPresswire.com/ -- Muscarinic Acetylcholine Receptor M2

Summary 

Muscarinic Acetylcholine Receptor M2 (CHRM2) - Muscarinic cholinergic receptor 2 is an acetylcholine receptor. It is expressed in various regions of the brain including the cerebellum, cerebral cortex, hippocampus, medulla, striatum, and thalamus, and in lung and prostate. It mediates smooth muscle contractility. Increase in M2 receptor has been associated with depression.

The report 'Muscarinic Acetylcholine Receptor M2 (CHRM2) - Pipeline Review, H1 2017' outlays comprehensive information on the Muscarinic Acetylcholine Receptor M2 (CHRM2) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type; that are being developed by Companies / Universities.

Click here for sample report @ http://www.wiseguyreports.com/sample-request/1510548-muscarinic-acetylcholine-receptor-m2-chrm2-pipeline-review-h1-2017

 

Scope of The Report

- The report provides a snapshot of the global therapeutic landscape for Muscarinic Acetylcholine Receptor M2 (CHRM2) 
- The report reviews Muscarinic Acetylcholine Receptor M2 (CHRM2) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources 
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages 
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities 
- The report reviews key players involved in Muscarinic Acetylcholine Receptor M2 (CHRM2) targeted therapeutics and enlists all their major and minor projects 

  Table of Contents 

List of Tables 
List of Figures 
Introduction 
Global Markets Direct Report Coverage 
Muscarinic Acetylcholine Receptor M2 (CHRM2) - Overview 
Muscarinic Acetylcholine Receptor M2 (CHRM2) - Therapeutics Development 
Products under Development by Stage of Development 
Products under Development by Therapy Area 
Products under Development by Indication 
Products under Development by Companies 
Muscarinic Acetylcholine Receptor M2 (CHRM2) - Therapeutics Assessment 
Assessment by Mechanism of Action 
Assessment by Route of Administration 
Assessment by Molecule Type 
Muscarinic Acetylcholine Receptor M2 (CHRM2) - Companies Involved in Therapeutics Development 
Allergan Plc 
Anavex Life Sciences Corp 
FemmePharma Global Healthcare Inc 
Juniper Pharmaceuticals Inc 

 .Continued

For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/1510548-muscarinic-acetylcholine-receptor-m2-chrm2-pipeline-review-h1-2017

About Us

Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here